The European Food Safety Authority (EFSA) aims to determine the safety of a new cocktail of food enzymes derived from a non-genetically modified strain of the fungus Trichoderma reesei. This evaluation primarily affects food manufacturers using enzymatic aids, regulatory bodies overseeing food safety, as well as consumers concerned about food ingredient safety standards. Reactions are expected from industrial stakeholders keen to understand compliance costs and from public interest groups advocating for stringent safety assurance.
This scientific opinion was published by EFSA on January 8, 2026, reflecting the expertise of its Panel on Food Contact Materials, Enzymes and Processing Aids, a specialized body responsible for assessing ingredient safety in food production.
The document is a scientific opinion, which falls short of legislation but provides an authoritative risk assessment. It does not impose mandatory measures but offers detailed evaluation of the enzyme mix’s safety based on toxicological and exposure data. The opinion includes concrete conclusions on safety but refrains from setting explicit numerical regulatory thresholds or implementation deadlines.
EFSA’s orientation is cautious but affirming regarding the enzyme blend’s use in food processing. It underscores that the Trichoderma reesei-derived enzymes do not pose safety concerns under intended conditions of use, tilting the scale towards facilitation of industrial enzyme applications. This assessment prioritizes consumer protection and hygiene standards while maintaining industrial innovation pathways, balancing potential risks against technological benefits.
The major stakeholders impacted include EFSA and other EU regulatory bodies who may adopt the assessment for formal regulatory decisions; food producers who might integrate these enzymes for improved processing efficiency; consumers who benefit from safer, well-characterized food ingredients; and public health organizations advocating rigorous evaluation of novel ingredients. While producers may face adaptation costs, the positive outcome supports safe innovation, while EFSA strengthens its role in scientific risk evaluation.
This scientific opinion represents a continuation of EFSA’s role in evaluating food enzyme safety rather than a legislative endpoint. The European Commission and member state authorities are likely to review and potentially incorporate these findings into food standards or authorization decisions, signaling the next procedural stage in ingredient regulation.
← Atlas › News › Agri-Food